Vancouver, British Columbia – October 25, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) is pleased to announce that CEO, Dr. Howard Verrico, has been invited by the Consulate of France in Vancouver and Business in France to present at a roundtable breakfast event at the Terminal City Club on October 26th, 2016.
The event will showcase opportunities for business in France and Canadian entrepreneurs. Dr. Verrico will speak on successfully completing and managing the acquisition of TFChem in France, the extensive government support received, the multiple licensing agreements the company has accomplished and the future of Sirona/TFChem.
Other speakers will include the French Ambassador, H.E. Mr. Nicolas Chapuis and Mr. Philippe Huberdeau, Minister Counselor for Economic Affairs.
For more information about this event: https://investinfrance.eventbrite.com
For more information regarding this announcement, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
About Sirona Biochem
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit www.sironabiochem.com
The event will showcase opportunities for business in France and Canadian entrepreneurs. Dr. Verrico will speak on successfully completing and managing the acquisition of TFChem in France, the extensive government support received, the multiple licensing agreements the company has accomplished and the future of Sirona/TFChem.
Other speakers will include the French Ambassador, H.E. Mr. Nicolas Chapuis and Mr. Philippe Huberdeau, Minister Counselor for Economic Affairs.
For more information about this event: https://investinfrance.eventbrite.com
For more information regarding this announcement, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
About Sirona Biochem
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit www.sironabiochem.com
